Intellia Therapeutics (NTLA) Asset Utilization Ratio (2016 - 2026)

Intellia Therapeutics (NTLA) has 11 years of Asset Utilization Ratio data on file, last reported at 0.08 in Q1 2026.

• Asset Utilization Ratio for Q1 2026 came in at 0.08, up 97.25% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.08 (up 97.25% YoY), and the FY2025 annual result was 0.07, up 43.31% from the prior year.
• Asset Utilization Ratio grew to 0.08 in Q1 2026 per NTLA's latest filing, from 0.08 in the prior quarter.
• Over five years, Asset Utilization Ratio peaked at 0.08 in Q1 2026 and troughed at 0.02 in Q1 2022.
• A 5-year average of 0.05 and a median of 0.04 in 2023 frame the typical range for Asset Utilization Ratio.
• On a YoY basis, Asset Utilization Ratio climbed as much as 136.33% in 2022 and fell as far as 66.48% in 2022.
• A 5-year view of Asset Utilization Ratio shows it stood at 0.04 in 2022, then retreated by 28.75% to 0.03 in 2023, then surged by 71.69% to 0.05 in 2024, then jumped by 56.41% to 0.08 in 2025, then advanced by 7.82% to 0.08 in 2026.
• Business Quant data shows NTLA's Asset Utilization Ratio at 0.08 in Q1 2026, 0.08 in Q4 2025, and 0.06 in Q3 2025.